Federal agencyVerified2026-11-10
National Institutes of Health
- Opportunities linked
- 749
- Recorded awards (total)
- $343,986,917,930
- Median recorded award
- $1,389,099
Records in this library attributed to this funder.
Sum of the awards we hold for this funder. A floor on its giving, not a filing total.
The midpoint of the awards we hold, not a cap and not a filing median.
- Data year
- Not stated
The most recent fiscal year among the awards we hold, as the source wrote it.
Why there is no giving history here
Award listings from USASpending are not connected yet. What is missing here is a feed on our side, not a document this funder has failed to publish - the listings are public and we have not connected them.
Derived from awards
Computed from the 6185 recipients we hold an award to. This is where money we can see went, which is not the same as a statement of what this funder sets out to fund — and the gap between the two is widest where our coverage is thinnest.
Programmes, by money awarded
- 93.855$37,603,430,32515561 awards
- 93.866$29,021,542,69811627 awards
- 93.859$28,312,929,31613277 awards
- 93.310$22,220,294,2993736 awards
- 93.837$21,711,813,29711017 awards
- 93.847$20,477,692,9339106 awards
- 93.242$20,308,340,5918291 awards
- 93.853$18,160,521,43610218 awards
- 93.279$16,759,788,4556161 awards
- 93.865$10,420,201,8106701 awards
- 93.395$10,398,605,5384036 awards
- 93.393$8,078,626,7303174 awards
- 93.396$7,178,467,1553332 awards
- 93.867$7,162,557,7473728 awards
- 93.353$6,665,199,287368 awards
Where the recipients are
The recipient's own location, not where the work happens. A national body headquartered in Washington spends money everywhere.
- CA $50,938,613,617
- NY $32,730,825,586
- MA $32,454,347,850
- PA $21,607,377,645
- TX $17,326,857,077
- NC $16,128,234,289
- MD $13,827,501,501
- WA $13,333,544,408
- IL $11,586,075,768
- MI $9,623,652,266
- OH $9,479,655,836
- FL $8,296,714,094
- GA $7,815,511,712
- CT $7,707,871,399
- MO $7,634,736,082
- MN $7,038,906,424
- TN $6,990,621,609
- WI $5,987,857,328
- CO $5,099,432,348
- VA $4,522,276,190
Award sizes
Fixed bands rather than this funder's own quantiles, so two funders can be compared. A per-funder split would make every distribution look the same shape.
- 100k-500k 37850
- 25k-100k 7862
- 500k-2m 44760
- over-2m 52424
- under-25k 1730
By fiscal year
A trend across the years we import, which is a bounded window. A year with no bar is a year outside it, not a year with no funding.
- FY1972 $7,781,340 (1)
- FY1974 $17,410,828 (2)
- FY1975 $885,835,634 (85)
- FY1976 $365,364,825 (41)
- FY1977 $779,079,794 (70)
- FY1978 $856,246,890 (57)
- FY1979 $418,420,741 (52)
- FY1980 $279,044,614 (49)
- FY1981 $264,333,498 (35)
- FY1982 $301,003,827 (36)
- FY1983 $361,705,895 (49)
- FY1984 $362,336,430 (50)
- FY1985 $453,495,098 (70)
- FY1986 $291,563,314 (41)
- FY1987 $439,849,674 (56)
- FY1988 $449,613,873 (57)
- FY1989 $575,645,073 (79)
- FY1990 $504,466,405 (86)
- FY1991 $609,729,356 (105)
- FY1992 $1,258,274,572 (136)
- FY1993 $718,076,924 (101)
- FY1994 $1,147,789,348 (152)
- FY1995 $835,311,432 (130)
- FY1996 $949,862,020 (142)
- FY1997 $8,810,015,943 (338)
- FY1998 $2,627,436,906 (204)
- FY1999 $2,377,014,146 (259)
- FY2000 $2,668,676,999 (285)
- FY2001 $3,806,697,730 (337)
- FY2002 $2,392,113,600 (298)
- FY2003 $2,645,675,002 (307)
- FY2004 $2,535,014,039 (316)
- FY2005 $2,931,504,280 (376)
- FY2006 $7,529,332,889 (325)
- FY2007 $4,541,066,128 (431)
- FY2008 $2,855,953,166 (406)
- FY2009 $3,662,388,585 (531)
- FY2010 $4,284,896,872 (712)
- FY2011 $5,247,655,983 (828)
- FY2012 $5,693,007,232 (949)
- FY2013 $6,281,286,552 (1131)
- FY2014 $11,889,737,864 (1893)
- FY2015 $13,025,486,325 (3444)
- FY2016 $22,161,451,253 (6409)
- FY2017 $23,248,183,644 (8586)
- FY2018 $24,605,628,493 (11550)
- FY2019 $31,559,649,125 (13799)
- FY2020 $27,995,053,960 (15559)
- FY2021 $26,976,424,267 (15913)
- FY2022 $27,139,357,213 (16091)
- FY2023 $23,074,363,717 (15515)
- FY2024 $16,767,266,938 (14143)
- FY2025 $11,220,426,635 (11656)
- FY2026 $20,004,931 (224)
- FY2030 $54,659 (1)
Giving history, from the awards we hold
No dated awards on file for this funder
This table takes one row per fiscal year, built from the awards we hold. We have connected none for this funder that state a year, so there is nothing to group. That is a gap in our coverage, not a finding that the funder gave nothing.
Who has received money from this funder
144626 awards on file, largest first, ranging $-3,000,000 to $1,073,967,938.
| Recipient | State | Amount | Fiscal year |
|---|---|---|---|
| MICROBIOTIX, INC. | Not stated | $300,156 | 2022 |
| COLORADO STATE UNIVERSITY | Not stated | $300,155 | 2025 |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | Not stated | $300,128 | 2020 |
| VENOVA TECHNOLOGIES INC | Not stated | $300,067 | 2022 |
| EPICYPHER, INC. | Not stated | $300,055 | 2019 |
| OHIO STATE UNIVERSITY, THE | Not stated | $300,017 | 2018 |
| FANNIN PARTNERS LLC | Not stated | $300,016 | 2025 |
| TRUSTEES OF BOSTON UNIVERSITY | Not stated | $300,014 | 2020 |
| PURDUE UNIVERSITY | Not stated | $300,011 | 2025 |
| UNIVERSITY OF TENNESSEE | Not stated | $300,007 | 2019 |
| DOTY SCIENTIFIC INC | Not stated | $300,001 | 2021 |
| INNOVAGYN INC | Not stated | $300,001 | 2021 |
| KINEOLABS, INC. | Not stated | $300,001 | 2025 |
| ACCELEVIR DIAGNOSTICS LLC | Not stated | $300,000 | 2018 |
| ACCELEVIR DIAGNOSTICS LLC | Not stated | $300,000 | 2020 |
| ACCELEVIR DIAGNOSTICS LLC | Not stated | $300,000 | 2021 |
| ACEPRE, LLC | Not stated | $300,000 | 2021 |
| ACHEMINALL CORPORATION | Not stated | $300,000 | 2024 |
| ADECTO PHARMACEUTICALS, INC. | Not stated | $300,000 | 2019 |
| AMBERSTONE BIOSCIENCES INC | Not stated | $300,000 | 2021 |
| AMERICAN COLLEGE OF RHEUMATOLOGY, INC | Not stated | $300,000 | 2022 |
| AMIDEBIO, LLC | Not stated | $300,000 | 2021 |
| ANALYTICAL DIAGNOSTIC SOLUTIONS INC | Not stated | $300,000 | 2023 |
| APT THERAPEUTICS, INC. | Not stated | $300,000 | 2019 |
| APT THERAPEUTICS, INC. | Not stated | $300,000 | 2020 |
| B2M MEDICAL INC | Not stated | $300,000 | 2022 |
| BARRETT TECHNOLOGY, LLC | Not stated | $300,000 | 2021 |
| BELLBROOK LABS LLC | Not stated | $300,000 | 2019 |
| BELLBROOK LABS LLC | Not stated | $300,000 | 2020 |
| BIOMORPH TECHNOLOGIES LLC | Not stated | $300,000 | 2021 |
| BIOMORPH TECHNOLOGIES LLC | Not stated | $300,000 | 2023 |
| BIOTHERAPEUTICS, INC. | Not stated | $300,000 | 2021 |
| BIOTHERAPEUTICS, INC. | Not stated | $300,000 | 2021 |
| BIOTHERAPEUTICS, INC. | Not stated | $300,000 | 2024 |
| BOLDER BIOTECHNOLOGY INC | Not stated | $300,000 | 2021 |
| BRIGHAM & WOMENS HOSPITAL INC | Not stated | $300,000 | 2021 |
| BRIGHAM & WOMENS HOSPITAL INC | Not stated | $300,000 | 2023 |
| BRIGHT CLOUD INTERNATIONAL CORP | Not stated | $300,000 | 2019 |
| BRIMROSE TECHNOLOGY CORP | Not stated | $300,000 | 2022 |
| CALLA HEALTH FOUNDATION | Not stated | $300,000 | 2020 |
| CAPTIS DIAGNOSTICS INC. | Not stated | $300,000 | 2019 |
| CAROGEN CORP | Not stated | $300,000 | 2020 |
| CEDARS-SINAI MEDICAL CENTER | Not stated | $300,000 | 2008 |
| CELL PRESERVATION SERVICES INC | Not stated | $300,000 | 2018 |
| CELL REPROGRAMMING & THERAPEUTICS LLC | Not stated | $300,000 | 2018 |
| CELL REPROGRAMMING & THERAPEUTICS LLC | Not stated | $300,000 | 2018 |
| CELLERGY PHARMA INC. | Not stated | $300,000 | 2024 |
| CFD RESEARCH CORPORATION | Not stated | $300,000 | 2019 |
| CFD RESEARCH CORPORATION | Not stated | $300,000 | 2022 |
| COLLAMEDIX INC | Not stated | $300,000 | 2023 |
| COLLAMEDIX INC | Not stated | $300,000 | 2023 |
| COLLAMEDIX INC | Not stated | $300,000 | 2024 |
| CYRUS BIOTECHNOLOGY, INC | Not stated | $300,000 | 2025 |
| DAVINCI BIO, INC. | Not stated | $300,000 | 2021 |
| DAY ZERO DIAGNOSTICS INC | Not stated | $300,000 | 2021 |
| ECHELON BIOSCIENCES INC. | Not stated | $300,000 | 2019 |
| EFFECTORBIO, INC. | Not stated | $300,000 | 2023 |
| ELECTRONIC BIOSCIENCES, INC. | Not stated | $300,000 | 2023 |
| EMMUNE INC | Not stated | $300,000 | 2025 |
| ENYX THERAPEUTICS LLC | Not stated | $300,000 | 2022 |
| EXHALIX, LLC | Not stated | $300,000 | 2021 |
| FORWARD DEFENSE, LLC | Not stated | $300,000 | 2022 |
| GEL4MED INC | Not stated | $300,000 | 2019 |
| GEL4MED INC | Not stated | $300,000 | 2020 |
| GENELANCET BIOSCIENCES INC | Not stated | $300,000 | 2022 |
| GENERAL NANOTHERAPEUTICS LLC | Not stated | $300,000 | 2022 |
| GIGAMUNE, INC. | Not stated | $300,000 | 2023 |
| GIGAMUNE, INC. | Not stated | $300,000 | 2024 |
| GLYCO EXPRESSION TECHNOLOGIES (CORPORATION) | Not stated | $300,000 | 2019 |
| GLYCOBIA INC | Not stated | $300,000 | 2019 |
| GLYCOMANTRA INC | Not stated | $300,000 | 2020 |
| GLYCOT THERAPEUTICS LLC | Not stated | $300,000 | 2019 |
| HARLINGENE LIFE SCIENCES LLC | Not stated | $300,000 | 2022 |
| HASENTECH, INC. | Not stated | $300,000 | 2020 |
| HBVTECH, L.L.C | Not stated | $300,000 | 2021 |
| HYDROCISION INC | Not stated | $300,000 | 2023 |
| IASO THERAPEUTICS INC | Not stated | $300,000 | 2020 |
| IMMPORT THERAPEUTICS INC | Not stated | $300,000 | 2025 |
| INDAPTA THERAPEUTICS INC | Not stated | $300,000 | 2019 |
| INDEE. INC. | Not stated | $300,000 | 2020 |
| IONIC PHARMACEUTICALS, LLC | Not stated | $300,000 | 2024 |
| JAN BIOTECH, INC. | Not stated | $300,000 | 2023 |
| KLEIN BUENDEL, INC. | Not stated | $300,000 | 2022 |
| LASMED LTD. LIABILITY CO. | Not stated | $300,000 | 2017 |
| LIFE PHARMS INC | Not stated | $300,000 | 2025 |
| LIFESENSORS INC | Not stated | $300,000 | 2020 |
| LUCERNA INC | Not stated | $300,000 | 2024 |
| LYNTHERA CORP | Not stated | $300,000 | 2021 |
| LYNTHERA CORP | Not stated | $300,000 | 2022 |
| MICRORID TECHNOLOGIES INC | Not stated | $300,000 | 2024 |
| MICROSENSOR LABS, LLC | Not stated | $300,000 | 2019 |
| MINNESOTA HEALTHSOLUTIONS CORPORATION | Not stated | $300,000 | 2022 |
| MINUTIA INC | Not stated | $300,000 | 2021 |
| NABGEN INC | Not stated | $300,000 | 2020 |
| NANOAFFIX SCIENCE LLC | Not stated | $300,000 | 2024 |
| NORTH CAROLINA CENTRAL UNIVERSITY | Not stated | $300,000 | 2024 |
| NORTHEASTERN UNIVERSITY | Not stated | $300,000 | 2015 |
| NORTHWESTERN UNIVERSITY | Not stated | $300,000 | 2022 |
| NORTIS INC | Not stated | $300,000 | 2019 |
| NOVELMED THERAPEUTICS, INC. | Not stated | $300,000 | 2021 |
Source: USASpending.gov federal award records. Federal awards only. Last synced 2026-09-15.
What this funder funds
Derived from how this funder's 749 linked opportunities are classified, not from a funding strategy the funder published.
- Health & Human Services749
- Education135
- Environment & Water46
- Food & Nutrition34
Currently open opportunities
Verified against each record's own source. The date on every row is the day we last checked that record — not the day this page was built.
- Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Centers for Genomics Research Capacity BuildingCloses Not statedChecked 2026-11-10
- Limited Competition: Community-Partnered Nursing Research Centers for Schools and Colleges of Nursing with Limited NIH Funding (P20 Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Environmental Determinants of Diabetes in The Young Study (TEDDY) Data Coordinating Center (U01 Clinical Trial Not Allowed)Closes Not statedAwards up to $6,000,000Checked 2026-11-10
- Forecast to Renew the Notice of Funding Opportunity Announcement for the Multiple Chronic Disease Research CentersCloses Not statedChecked 2026-11-10
- Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- NIEHS Worker Training Program’s SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)Closes Not statedChecked 2026-11-10
- Infrastructure for Population Dynamics Research Program (iPOP)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional)Closes Not statedChecked 2026-11-10
- Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional)Closes Not statedChecked 2026-11-10
- Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional)Closes Not statedChecked 2026-11-10
- Notice of Intent to Publish a Funding Opportunity Announcement for HIV Pediatric, Adolescent and Maternal Clinical TrialsCloses Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials not allowed)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not allowed)Closes Not statedChecked 2026-11-10
- Funding Opportunity Announcement for Impact of Environmental Exposures on Gut-Brain Signaling in Neurological Conditions (R01)Closes Not statedChecked 2026-11-10
- Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Technology and Digital Media Exposure Usage on Child and Adolescent DevelopmentCloses Not statedChecked 2026-11-10
- Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)Closes Not statedChecked 2026-11-10
- Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Notice of Funding Opportunity Announcement for Addressing Determinants of Health Disparities Among Rural Populations (R01 - Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast to Renew the Funding Opportunity Announcement for Multiple Chronic Disease Research Centers Coordinating Center (U24 Clinical Trial Not Required)Closes Not statedChecked 2026-11-10
What this funder’s awards look like
Counted over the award rows we hold for this funder. These are statistics over published records, not a model’s reading of them, and not a prediction.
Awards on file144626
Distinct recipients5767
Median award$1,389,137
Included with Studio
The counts and the median above stay free, because they are the evidence for everything else. Studio adds the breakdowns: which states the awards went to, what kind of organisation received them, and how the amounts are distributed.
See what Studio includes